Novo Nordisk Posted October 2, 2026

Director, Search & Evaluation (Cambridge, MA, US)

Cambridge, United States Type not listed
Notify me about similar jobs

Novo Nordisk is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

About the Department

The Novo Cambridge location is the headquarters for Global Business Development across all of our therapeutic and technology areas. We contribute to innovation in one of the world's largest life sciences ecosystems by participating in events and discussions with renowned and upcoming scientists looking for the next scientific breakthrough to bring transformative treatments to patients. We work with start-ups, established companies and venture capitalists to support the development of innovation for mutual benefit, and to help patients in all of our current therapy areas. Through a variety of partnership models, we accelerate ideas from the lab and clinic to advance and expand our product portfolio and to improve outcomes for the patients we serve

The Position

Global Business Development (GBD) contributes to innovation in one of the world's largest life sciences ecosystems by participating in events and discussions with renowned and upcoming scientists–looking for the next scientific breakthrough to bring transformative treatments to patients. We work with start-ups, established companies and venture capitalists to support the development of innovation for mutual benefit and to help patients in all of our current therapy areas. Through a variety of partnership models, we accelerate ideas from the lab and clinic to advance and expand our product portfolio and to improve outcomes for the patients we serve. Search, Evaluation & Intelligence (SE&I) is part of GBD and acts as the primary entry point for external drug and technology opportunities relevant to Novo.

The search for novel therapeutics focuses on diabetes, obesity, liver and CVD, blood & endocrine disorders as well as Consumer Rx. Besides our therapeutic areas of interest, SE&I supports the identification of cutting-edge enabling technologies across several modalities. Working cross-functionally, SE&I supports the assessment of such external opportunities all the way through due diligence and contractual negotiation, and this role is  directly responsible for cross-functionally leading evaluations of BD opportunities from initial evaluation through due diligence.

Relationships

The position is part of the global SE&I evaluation team with members located predominantly in Denmark and Cambridge, MA, US. Reports to the Head of Global Evaluation. The role will interact cross-functionally with stakeholders from the entire value chain while working in close collaboration with Novo’s Business Development teams located in Denmark and Cambridge. This position will also leverage their networks and actively engage with external stakeholders including biotech companies, venture capital firms and large-cap pharma communities. The role has no direct or indirect reports.

Essential Functions

Identify novel pipeline assets and enabling technologies

Lead in-depth evaluation and due diligence process

Provide support to Business Development during negotiation of licenses and collaborations in alignment with SE&I

Work cross-organizationally with stakeholders from R&D to Commercial and beyond to ensure alignment

Build and maintain BD opportunity landscapes

Continuously provide input to BD priorities and Therapy area strategies

Establish Novo as the preferred partner within relevant therapy areas

Actively engage with external stakeholders particularly venture capital, biotech companies and other large-cap pharma

Participate in partnering events, scientific conferences and other relevant networking events

Physical Requirements

10-20% overnight travel required; May require international travel.

Qualifications

Master’s degree in business or life science is required; MD or PhD degree preferred

12+ years' relevant experience with a Master’s degree; 10+ years’ relevant experience with a MD or PhD.  Relevant experience includes prior experience in a consultancy, M&A house, in-house corporate development role or equivalent R&D role

Relevant experience includes:

Building extensive professional network in biotech and VC communities particularly related to metabolic diseases

Research and medical training, preferably in a relevant medical field

Business development and licensing experience covering aspects of pharmaceutical drug discovery and development preferred

Proven track record of project management

Ability to manage ambiguity and manage and be ready for change

Ability to analyse and digest complex ideas and data to make clear and qualified recommendations to senior stakeholders

Strong communication skills, both in written and presentation form

Outgoing with superb networking, collaboration and stakeholder management skills

Self-driven, solution-focused and goal-oriented who functions well in a dynamic environment

Strong strategic business and financial acumen coupled with deep interest and curiosity about life sciences and medicine

The base compensation range for this position is $187,100 to $327,500. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance. Novo offers long-term incentive compensation and or company vehicles depending on the position's level or other company factors.

Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex-able vacation policy and parental leave policy.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo, we're not chasing quick fixes – we're creating lasting change for long-term health. For over 100 years, we've been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of what's possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, we're making healthcare more accessible, treating and defeating diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger – a legacy of impact that reaches far beyond today.

Novo is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.

If you are interested in applying to Novo and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.

]]>

Job details

Seniority
Director
Function
BD&L & Strategic Planning
Therapeutic area
Not listed
Location
Cambridge, United States
Employment type
Not listed

How this role compares

Computed from every other active BD&L & Strategic Planning role in our database, not just this employer's listings.

We currently track 131 comparable Director BD&L & Strategic Planning roles across 46 biopharma companies.

131Comparable roles tracked
122Currently active
46Companies hiring similar roles
16Countries represented

Salary context

52 of 131 peers report a salary range (USD, annualized)

Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.

This roleSubject Not listed on this posting
Lowest disclosed · Principal Scientist II, Translational Biomarker Strategy Lead · Novartis $114,100/yr – $211,900/yr
Highest disclosed · Sr. Director, US Policy Strategy · CSL Behring L.L.C. $297,000/yr – $364,000/yr
Peer group range $163,000 – $330,500 (median $234,650)

Where these roles are based

Top locations among the 131 comparable roles

United States85
China19
Japan5
United Kingdom5
Switzerland3
France2

+ 10 more countries

Seniority mix

131 of 131 peers have a known seniority level

Director93
Senior Director30
Principal8

Therapeutic area mix

34 of 131 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology11
Neuroscience11
Immunology8
Respiratory2
Dermatology & Aesthetics1
Vaccines & Infectious Disease1

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

60%similar
Amgen Inc. Remote, United States Director
Same function Same seniority Same country
60%similar
Boehringer Ingelheim Fremont, California, United States Director
Same function Same seniority Same country
60%similar
Boehringer Ingelheim Ridgefield, Connecticut, United States Director
Same function Same seniority Same country
60%similar
Merck Rahway, New Jersey, United States Director
Same function Same seniority Same country
60%similar
AbbVie North Chicago, IL Director
Same function Same seniority Same country
60%similar
AbbVie North Chicago, IL Director
Same function Same seniority Same country

Notify me about similar jobs

Get an email when we spot other openings like this one – same job function, comparable seniority, roles you'd actually want to see.

Or follow a whole field: get every new BD&L & Strategic Planning job in the United States, and choose locations and companies.

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

60%
Oncology Strategy Director
Amgen Inc. · Remote, United States · Director
Function Therapeutic area Seniority Country
60%
Director, Operational Technology Security Strategy & Execution (Hiring Our Heroes Corporate Fellow)
Merck · Rahway, New Jersey, United States · Director
Function Therapeutic area Seniority Country
60%
Director, Employee Experience and Talent Strategy
AstraZeneca · Wilmington, Delaware, United States of America · Director
Function Therapeutic area Seniority Country
60%
Licensing & Business Development Director
Merck KGaA · Burlington, Massachusetts, United States · Director
Function Therapeutic area Seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.